Dr. Lara Scheherazade Milane is a Bouvé College of Health Sciences Distinguished Educator and Assistant Teaching Professor in the Department of Pharmaceutical Sciences at Northeastern University, Boston, MA. She recently designed and developed Anti-metastatic Communication Inhibiting Nanomedicine (A-COIN) for treating drug-resistant breast, ovarian, and endometrial cancer (2025); Mitochondrial Network Enhancing (MiNE) nanoparticles for treating neurodegenerative disease (2025); and Combination Organelle Mitochondrial Endoplasmic reticulum Therapy (COMET) for treating multidrug-resistant triple negative breast cancer (2023). Dr. Milane’s research interests include mitochondrial nanomedicine, tunneling nanotube communication, extracellular vesicles communication, and developing nanotechnology-based solutions to manipulate cell communication in multidrug-resistant female cancers and neurodegenerative diseases. She coined cancer as “molecular evolution” and “survival of the fittest at its finest” and identified three emerging hallmarks of cancer—plasticity, heterogeneity, and quiescence (2017). Dr. Milane has authored 28 peer-reviewed journal publications, 9 book chapters, 3 white papers, and is the editor of 5 books, with two additional books in progress. She is also an advocate for women in science and promoting early/pre-college scientific interest and competency.